R-Pharm Has Completed Enrollment for the Phase III Clinical Trial of Taigexyn in Community Acquired Pneumonia in Russia_2017_News

Nov 27, 2017

R-Pharm Has Completed Enrollment for the Phase III Clinical Trial of Taigexyn in Community Acquired Pneumonia in Russia